Two Sigma Investments’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172K Sell
23,093
-57,556
-71% -$437K ﹤0.01% 4309
2025
Q4
$752K Buy
80,649
+41,654
+107% +$393K ﹤0.01% 3098
2025
Q3
$382K Buy
38,995
+26,922
+223% +$246K ﹤0.01% 3110
2025
Q2
$87K Buy
12,073
+1,023
+9% +$6.12K ﹤0.01% 3012
2025
Q1
$91.2K Buy
+11,050
New +$242K ﹤0.01% 2972
2024
Q3
Sell
-748
Closed -$6.55K 3098
2024
Q2
$6.55K Buy
748
+3
+0.4% +$53 ﹤0.01% 2971
2024
Q1
$18.3K Hold
745
﹤0.01% 2934
2023
Q4
$12.4K Sell
745
-172
-19% -$2.96K ﹤0.01% 3075
2023
Q3
$17.1K Sell
917
-250
-21% -$5.54K ﹤0.01% 2876
2023
Q2
$28.3K Sell
1,167
-1,107
-49% -$29.7K ﹤0.01% 2883
2023
Q1
$49.7K Sell
2,274
-1,343
-37% -$51.3K ﹤0.01% 2755
2022
Q4
$86.2K Sell
3,617
-1,360
-27% -$34.3K ﹤0.01% 2527
2022
Q3
$137K Sell
4,977
-2,839
-36% -$94.3K ﹤0.01% 2188
2022
Q2
$236K Sell
7,816
-292
-4% -$9.92K ﹤0.01% 2110
2022
Q1
$436K Buy
8,108
+5,413
+201% +$433K ﹤0.01% 2084
2021
Q4
$800K Sell
2,695
-900
-25% -$328K ﹤0.01% 2766
2021
Q3
$1.39M Buy
+3,595
New +$1.42M ﹤0.01% 2312

Other funds holding ALGS